new protocols by visualizing multiple tracers simultaneously
for new insights with 3D Dynamic Acquisition¹
existing tracers to help expand their clinical applications
the development of new tracers
Extended FOV processing for a 76% increase in FOV volume²
Combine dynamic acquisition on MyoSPECT with CFR and aboslute myocardial blood flow
Evaluate attenuation by imaging in prone and supine positions, or combine the perfusion images with separate CT images on Xeleris
Automated scan position and FOV recommendations
by remotely collaborating with a clinician mid-exam
with simplified workflows for complex procedures
helps your department operate efficiently
with automated transfer and archive features
Has the smallest footprint of all our 800 Series SPECT/CT systems
with simplified workflows for complex procedures
Leveraging the CT technology you need for anatomical localization and attenuation correction
Shares the same modular design as the rest of the 800 Series family of nuclear medicine systems
by up to 25 percent with the increased sensitivity of SwiftScan Planar and SwiftScan SPECT5
for greater patient comfort, with Evolution technology6
with SwiftScan Planar and SwiftScan SPECT’s improved small lesion detectability4
CZT is the key component to the future of nuclear medicine. Not only is it lighter and more compact than the Nal crystals used in analog technology, it is pixelated. With registered collimation, each photon is directly converted into an electrical signal that more accurately identifies its location and energy. The result is increased spatial and energy resolution.
2. As compared to Discovery™ NM 530c.
3. In clinical practice, the use of NM/CT CZT 870 with WEHR collimator may improve lesion detectability depending on the clinical task, patient size, anatomical location and clinical practice. A consultation with a radiologist and a physicist should be made to determine the appropriate dose or scan time to obtain diagnostic image quality for the particular clinical task.
4. As demonstrated in phantom testing using a model observer. For SPECT, compared to using the LEHR Collimator and a SPECT Step & Shoot acquisition. For Planar, compared to using LEHR without Clarity 2D.
5. Compared to LEHR collimator, with Step & Shoot scan mode (for SPECT) / without Clarity 2D (for Planar). As demonstrated in phantom testing using a bone scan protocol, Evolution processing (for SPECT), and a model observer. Because model observer results may not always match those from a human reader, the actual time/dose reduction depends on the clinical task, patient size, anatomical location and clinical practice. A radiologist should determine the appropriate scan time/dose for the particular task.
6. In clinical practice, Evolution options6a (Evolution for Bone, Evolution for Cardiac, Evolution for Bone Planar) and Evolution Toolkit6b are recommended for use following consultation of a Nuclear Medicine physician, physicist and/or application specialist to determine the appropriate dose or scan time reduction to obtain diagnostic image quality for a particular clinical task, depending on the protocol adopted by the clinical site.
6a. Evolution Options - Evolution claims are supported by simulation of count statistics using default factory protocols and imaging of 99mTc based radiotracers with LEHR collimator on anthropomorphic phantom or realistic NCAT - SIMSET phantom followed by quantitative and qualitative images comparison.
6b. Evolution Toolkit - Evolution Toolkit claims are supported by simulation of full count statistics using lesion simulation phantom images based on various radiotracers and collimators and by showing that SPECT image quality reconstructed with Evolution Toolkit provide equivalent clinical information but have better signal-to-noise, contrast, and lesion resolution compared to the images reconstructed with FBP / OSEM.